quality of life of subjects [1, 2]. AF increases morbidity and mortality even after adjusting for
comorbid cardiovascular conditions [3, 4]. Identification of predicting factors, especially
biomarkers, for AF is desirable for prediction and risk stratification of AF. Newly developed
high-sensitive troponin T (hsTnT) assay has improved early diagnosis of acute coronary
syndromes and risk stratification [5, 6]. Moreover, minor elevation of circulating hsTnT was …